Improved Renal Outcomes in Kidney Transplant Recipients with Early Denovo DSAs on Belatacept versus Calcineurin Inhibitor-Based Immunosuppression

被引：0
|
作者：
Gattis, S. [1 ]
Agrawal, M. [2 ]
Pang, S. [2 ]
Basu, A. [1 ]
机构：
[1] Emory Healthcare, Atlanta, GA USA
[2] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A194
引用
下载
收藏
页码：S698 / S698
页数：1
相关论文
共 50 条
  • [21] Belatacept Based Immunosuppression and Incidence of Proteinuria in Kidney Transplant Recipients
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [22] Utilization and clinical outcomes of belatacept- based immunosuppression in US renal transplant recipients
    Wen, Xuerong
    JinCasey, Michael
    Santos, Alfonso H.
    Hartzema, Abraham
    Womer, Karl
    TRANSPLANTATION, 2016, 100 (07) : S81 - S81
  • [23] Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients
    Paplaczyk, K.
    Cunningham, K.
    D'Agostino, C.
    Pinelli, D.
    Schulte, J.
    Shetty, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 439 - 440
  • [24] Calcineurin Inhibitor-Based Maintenance Immunosuppression in Lung Transplant Recipients: Optimal Serum Levels for Managing Acute Rejection and Renal Function
    McPheeters, Chelsey M.
    Lorenz, Douglas
    Burcham, Pamela K.
    Barger, Christopher D.
    Bhandari, Bikash
    Bauldoff, Gerene S.
    Truelove, Daniel B.
    Nunley, David R.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (06) : 1998 - 2003
  • [25] Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients
    Moein, Mahmoudreza
    Dvorai, Reut Hod
    Li, Benson W.
    Fioramonti, P. J.
    Schilsky, Juliana B.
    Thankachan, Reeba
    Yang, Christine
    Saidi, Reza F.
    Shahbazov, Rauf
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [26] Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
    Ivulich, Steven
    Paul, Eldho
    Kirkpatrick, Carl
    Dooley, Michael
    Snell, Greg
    TRANSPLANT INTERNATIONAL, 2023, 36
  • [27] 3-YEAR OUTCOMES AFTER SWITCHING TO BELATACEPT FROM A CALCINEURIN INHIBITOR IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Kamar, Nassim
    Rial, Maria
    Alberu, Josefina
    Steinberg, Steven M.
    Manfro, Roberto
    Nainan, Georgy
    Vincenti, Flavio
    Jones-Burton, Charlotte
    Grinyo, Josep M.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 44 - 44
  • [28] THREE-YEARS OUTCOMES AFTER SWITCHING TO BELATACEPT FROM CALCINEURIN INHIBITOR IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Kamar, N.
    Rial, M.
    Alberu, J.
    Steinberg, S.
    Manfro, R.
    Nainan, G.
    Vicenti, F.
    Jones-Burton, C.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 22 - 22
  • [29] Evaluation of a Belatacept-Based Immunosuppression Regimen in Kidney Transplant Recipients
    Brisku, R.
    Rudzik, K.
    Augustine, J.
    Eckardt, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S848 - S849
  • [30] Renal Preservation with Belatacept-Based versus Everolimus-Based Immunosuppression in Lung Transplant Recipients
    Sartain, E.
    Schoeppler, K.
    Crowther, B.
    Smith, J.
    Gray, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 383 - 383
12345